Low-dose dexamethasone with fosaprepitant and palonosetron to prevent cisplatin-induced nausea and vomiting in head and neck cancer patients.

Takashi Kono,Tsutomu Ueda,Masaya Takumida,Hiromi Furuie,Takao Hamamoto,Sachio Takeno,Katsuhiro Hirakawa

Acta oto-laryngologica（2018）

引用 3|浏览6

暂无评分

摘要

The efficacy of low-dose dexamethasone with fosaprepitant and palonosetron was not inferior to that of the standard dose dexamethasone in the highly emetogenic cisplatin-based treatment for head and neck cancer patients.

查看译文

关键词

CINV,HEC,Head and neck cancer,aprepitant,dexamethasone,fosaprepitant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要